AEON Biopharma, Inc. — Rendiconto Finanziario Trimestrale (NYSE:AEON)

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 23.4332 M
Employee 5
Founded 2013
CEO Murthy Simhambhatla
Website www.aeonbiopharma.com
Headquarter Delaware, United States
FIGI BBG00Z17HDW3
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

23.43 M Capitalizzazione di mercato

AEON Biopharma Inc Class A

Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology.

AEON

Financials

AEON Biopharma Inc Class A

Notizie

AEON Biopharma annuncia progressi sul biosimilare e finanziamenti

AEON Biopharma nomina John Bencich direttore finanziario

AEON Biopharma names John Bencich as chief financial officer

Il titolo di Aeon Biopharma crolla dopo l’incontro con la FDA e la ristrutturazione del debito

Aeon Biopharma stock falls after FDA meeting and debt restructuring

AEON Biopharma completa incontro con FDA, azionisti approvano transazioni

AEON Biopharma completes FDA meeting, shareholders approve transactions

AEON and Daewoong finalize $15 million debt-to-equity exchange deal

Ocado’s robotic future under threat as Kroger looks to Instacart

AEON Biopharma schedules FDA meeting to review botox biosimilar data

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025